SEC Filing Summary: The Cooper Companies, Inc. (COO)
Business Context and Reporting Period
This Form 8-K, dated August 27, 2025, reports the fiscal third quarter results for The Cooper Companies, Inc., a medical device manufacturer, for the period ended July 31, 2025. The filing incorporates by reference a press release issued on the same date detailing the company's operational and financial performance.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the text of this 8-K form.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the body text. Investors must refer to the incorporated press release for comparative analysis of the fiscal third quarter ended July 31, 2025, against prior periods.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, risk factors, and contingencies are not detailed in the 8-K text itself. The filing explicitly states that the press release contains the relevant information. No unusual items are described in the provided text.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific revenue and earnings figures for the quarter ended July 31, 2025.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check for any updated full-year guidance or outlook statements issued on August 27, 2025.
- Confirm the status of the company's debt and liquidity position as disclosed in the press release.